{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:00:55Z","timestamp":1792785655484,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602262"],"award-info":[{"award-number":["81602262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Youth Scholar Program of Tongji University","award":["2015KJ062"],"award-info":[{"award-number":["2015KJ062"]}],"id":[{"id":"https:\/\/ror.org\/03rc6as71","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ebiom.2019.02.051","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T18:12:51Z","timestamp":1551463971000},"page":"156-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling"],"prefix":"10.1016","volume":"41","author":[{"given":"Feifei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-5473","authenticated-orcid":false,"given":"Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ebiom.2019.02.051_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer","volume":"31","author":"Masoumi Moghaddam","year":"2012","journal-title":"Cancer Metastasis Rev."},{"issue":"10103","key":"10.1016\/j.ebiom.2019.02.051_bb0010","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ebiom.2019.02.051_bb0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","article-title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol."},{"issue":"22","key":"10.1016\/j.ebiom.2019.02.051_bb0020","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2009.26.9571","article-title":"Phase II, open-label study of pazopanib or lapatinib monotherapy compared with Pazopanib plus Lapatinib combination therapy in patients with advanced and recurrent cervical cancer","volume":"28","author":"Monk","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"10023","key":"10.1016\/j.ebiom.2019.02.051_bb0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(15)01167-8","article-title":"Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"387","author":"Ledermann","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2019.02.051_bb0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2019.02.051_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-015-0310-8","article-title":"Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer","volume":"14","author":"Barr","year":"2015","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.ebiom.2019.02.051_bb0040","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-11-4058","article-title":"VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression","volume":"72","author":"Cao","year":"2012","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.051_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4161\/cam.23332","article-title":"Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion","volume":"6","author":"Perrot-Applanat","year":"2012","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.ebiom.2019.02.051_bb0050","first-page":"1","article-title":"Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer","volume":"3","author":"Golfmann","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.051_bb0055","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI65385","article-title":"Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer","volume":"123","author":"Chatterjee","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ebiom.2019.02.051_bb0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2013.10.011","article-title":"Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway","volume":"146","author":"Zhang","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.051_bb0065","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.27236","article-title":"Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma","volume":"60","author":"Peng","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.051_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20111424","article-title":"Autocrine VEGF\u2013VEGFR2\u2013Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth","volume":"209","author":"Hamerlik","year":"2012","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.051_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.23963","article-title":"Autocrine VEGF-A\/KDR loop protects epithelial ovarian carcinoma cells from anoikis","volume":"124","author":"Sher","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2019.02.051_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2011.12.014","article-title":"Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT","volume":"318","author":"Lee","year":"2012","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ebiom.2019.02.051_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cell.2009.12.046","article-title":"Autocrine VEGF Signaling synergizes with EGFR in tumor cells to promote epithelial Cancer development","volume":"140","author":"Lichtenberger","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2019.02.051_bb0090","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1349-7006.2008.00860.x","article-title":"Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity","volume":"99","author":"Jin","year":"2008","journal-title":"Cancer Sci."},{"issue":"13","key":"10.1016\/j.ebiom.2019.02.051_bb0095","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1073\/pnas.131590998","article-title":"CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia","volume":"98","author":"Yang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.051_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2008.04.035","article-title":"RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells","volume":"269","author":"Wang","year":"2008","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.051_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085705","article-title":"OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells","volume":"9","author":"Rao","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.ebiom.2019.02.051_bb0110","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/carcin\/bgu070","article-title":"OVA66 increases cell growth, invasion and survival via regulation of IGF-1R\u2013MAPK signaling in human cancer cells","volume":"35","author":"Rao","year":"2014","journal-title":"Carcinogenesis"},{"issue":"W1","key":"10.1016\/j.ebiom.2019.02.051_bb0120","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.051_bb0125","first-page":"810","article-title":"NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer","volume":"8","author":"Han","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.ebiom.2019.02.051_bb0130","first-page":"519","article-title":"NudCD1 affects renal cell carcinoma through regulating LIS1\/dynein signaling pathway","volume":"10","author":"He","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.051_bb0135","first-page":"671","article-title":"The impact of NudCD1 on renal carcinoma cell proliferation, migration, and invasion","volume":"22","author":"Wang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419301306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419301306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T10:32:57Z","timestamp":1572777177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419301306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"alternative-id":["S2352396419301306"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.051","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}